» Articles » PMID: 24239118

Activation of GABAergic Neurons in the Interpeduncular Nucleus Triggers Physical Nicotine Withdrawal Symptoms

Overview
Journal Curr Biol
Publisher Cell Press
Specialty Biology
Date 2013 Nov 19
PMID 24239118
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chronic exposure to nicotine elicits physical dependence in smokers, yet the mechanism and neuroanatomical bases for withdrawal symptoms are unclear. As in humans, rodents undergo physical withdrawal symptoms after cessation from chronic nicotine characterized by increased scratching, head nods, and body shakes.

Results: Here we show that induction of physical nicotine withdrawal symptoms activates GABAergic neurons within the interpeduncular nucleus (IPN). Optical activation of IPN GABAergic neurons via light stimulation of channelrhodopsin elicited physical withdrawal symptoms in both nicotine-naive and chronic-nicotine-exposed mice. Dampening excitability of GABAergic neurons during nicotine withdrawal through IPN-selective infusion of an NMDA receptor antagonist or through blockade of IPN neurotransmission from the medial habenula reduced IPN neuronal activation and alleviated withdrawal symptoms. During chronic nicotine exposure, nicotinic acetylcholine receptors containing the β4 subunit were upregulated in somatostatin interneurons clustered in the dorsal region of the IPN. Blockade of these receptors induced withdrawal signs more dramatically in nicotine-dependent compared to nicotine-naive mice and activated nonsomatostatin neurons in the IPN.

Conclusions: Together, our data indicate that therapeutic strategies to reduce IPN GABAergic neuron excitability during nicotine withdrawal, for example, by activating nicotinic receptors on somatostatin interneurons, may be beneficial for alleviating withdrawal symptoms and facilitating smoking cessation.

Citing Articles

GABA receptor-mediated potentiation of ventral medial habenula glutamatergic transmission in GABAergic and glutamatergic interpeduncular nucleus neurons.

Stinson H, Ninan I bioRxiv. 2025; .

PMID: 39803438 PMC: 11722340. DOI: 10.1101/2025.01.03.631193.


Effects of E-Cigs on Physiological Pathways and Proposed Therapeutic Intervention with Bixin.

Claymore S, Allen-Gipson D Biomedicines. 2025; 12(12.

PMID: 39767612 PMC: 11673039. DOI: 10.3390/biomedicines12122705.


Striatal Cholinergic Interneurons Control Physical Nicotine Withdrawal via Muscarinic Receptor Signaling.

Kim B, Kim H, Woo J, Lee H, Kim T, Min H Adv Sci (Weinh). 2024; 11(47):e2402274.

PMID: 39491887 PMC: 11653618. DOI: 10.1002/advs.202402274.


The influence of ovarian hormones on the putative mechanisms that promote female nicotine use.

Giner P, Ortegon S, Bagdas D, ODell L Curr Opin Neurobiol. 2024; 88:102900.

PMID: 39153250 PMC: 11560049. DOI: 10.1016/j.conb.2024.102900.


Abundant extrasynaptic expression of α3β4-containing nicotinic acetylcholine receptors in the medial habenula-interpeduncular nucleus pathway in mice.

Tsuzuki A, Yamasaki M, Konno K, Miyazaki T, Takei N, Tomita S Sci Rep. 2024; 14(1):14193.

PMID: 38902419 PMC: 11189931. DOI: 10.1038/s41598-024-65076-3.


References
1.
Salas R, Pieri F, De Biasi M . Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit. J Neurosci. 2004; 24(45):10035-9. PMC: 6730195. DOI: 10.1523/JNEUROSCI.1939-04.2004. View

2.
Kenny P, Markou A . Neurobiology of the nicotine withdrawal syndrome. Pharmacol Biochem Behav. 2002; 70(4):531-49. DOI: 10.1016/s0091-3057(01)00651-7. View

3.
Grabus S, Martin B, Batman A, Tyndale R, Sellers E, Damaj M . Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology (Berl). 2004; 178(2-3):183-92. DOI: 10.1007/s00213-004-2007-3. View

4.
Hikosaka O . The habenula: from stress evasion to value-based decision-making. Nat Rev Neurosci. 2010; 11(7):503-13. PMC: 3447364. DOI: 10.1038/nrn2866. View

5.
Jackson K, Martin B, Changeux J, Damaj M . Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther. 2008; 325(1):302-12. PMC: 3821841. DOI: 10.1124/jpet.107.132977. View